A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

For some creatures, a lost body part is not necessarily a permanent affair. Salamanders can regrow limbs and zebrafish can ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Fintel reports that on April 21, 2025, William Blair initiated coverage of Xencor (NasdaqGM:XNCR) with a Outperform ...

PROVIDENCE, R.I., April 21, 2025 /PRNewswire/ -- EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as "Tregitopes" on antibody maturation ...

The deal is a blast from the not-too-distant past, when special purpose acquisition companies were an easy way for companies ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...